Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in a Multiple Sclerosis Patient Cohort

NCT02965170 is registered in ClinicalTrials.gov with Rocky Mountain MS Research Group, LLC as lead sponsor.

NCT NCT02965170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02965170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in a Multiple Sclerosis Patient Cohort
Lead sponsor
Rocky Mountain MS Research Group, LLC
Phase
Observational
Overall status
Completed
Start date
October 31, 2016
Completion date
May 31, 2018
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis